Delivery Order SPE2DR25D3201-SPE2DR26FT4JX
- Not listed
- The Defense Logistics Agency awarded a $41,055.70 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by December 5, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,479.16. The contract, issued on December 2, 2025, with completion expected by December 3, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime...
- The Defense Logistics Agency awarded a $21,156.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-set-aside contract, which is due for completion by November 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a $4,718.30 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $17,017.67 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's headquarters location...
- The Defense Logistics Agency awarded a $5,128.38 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,017.21 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $11,966.22 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $7,437.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive, competitively awarded delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4JXDelivery Order
The Defense Logistics Agency awarded a $27,437.03 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is set to be completed by December 3, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal healthcare needs, particularly for military and veteran systems. As the prime contractor under the DLA's comprehensive pharmaceutical supply vehicle, the company fulfills delivery orders for a diverse portfolio of medications and medical supplies across multiple therapeutic domains. This specific order for Dupixent, a specialty pharmaceutical used in treating atopic dermatitis and other conditions, reflects AmerisourceBergen's role in supporting the Defense Health Agency and other federal healthcare systems through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 12/1/25 |